跳至主要内容
临床试验/NL-OMON35637
NL-OMON35637已完成不适用

Whole clotting assessment as predictor of clinical phenotype in patients with severe haemophilia A - HAEMOTYPE study

Academisch Medisch Centrum0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • patients with severe haemophilia A (FVIII <0.01 IU/mL)
  • patient aged 5 to 25 years
  • patient with first bleeding at least 5 years ago
  • patient known at the Haemophilia Treatment Center of the Academic Medical Center
  • patient who visit the Haemophilia Treatment Center for routine blood testing (inhibitor testing)
  • patient whose age of first bleeding and bleeding data have been recorded
  • written informed consent from patient or in minors from parents/guardians is given

排除标准

  • patient with inhibitor in the past
  • administration FVIII concentrate < 72 hours prior to blood sampling
  • acquired coagulation disorders by hepatic dysfunction
  • use of ASA or NSAID's

研究者

相似试验

Whole clotting assessment as predictor of clinical... | 临床试验